Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · page 20 of 38
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 list 1/1 source-note 1/1 table 1/1 title 1/1
Components 5
primary bullet source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.